Cargando…

SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus

Background: Adipsic diabetes insipidus (ADI) is a rare condition with approximately 100 reported cases word wide. Inpatient management can be challenging as patients are predisposed to dysnatremia during this time. Societal guidelines offer little guidance in management of this complex disease. Case...

Descripción completa

Detalles Bibliográficos
Autores principales: Weaver, Travis, Hoang, Thanh, Warnock, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552815/
http://dx.doi.org/10.1210/js.2019-SUN-407
_version_ 1783424674930098176
author Weaver, Travis
Hoang, Thanh
Warnock, Alicia
author_facet Weaver, Travis
Hoang, Thanh
Warnock, Alicia
author_sort Weaver, Travis
collection PubMed
description Background: Adipsic diabetes insipidus (ADI) is a rare condition with approximately 100 reported cases word wide. Inpatient management can be challenging as patients are predisposed to dysnatremia during this time. Societal guidelines offer little guidance in management of this complex disease. Case: A 62-year-old woman with a history of acromegaly with transphenoidal resection more than 20 years ago, complicated by post-operative hypothyroidism, adrenal insufficiency and adipsic diabetes insipidus presented for admission for a planned cycle on of chemotherapy for her recently diagnosed diffuse large B-cell lymphoma. At admission her initial serum sodium was 130 mmol/L (reference 135-145 mmol/L) near her baseline level. During her 8 day stay she experienced significant fluctuations of serum sodium with a peak level of 151 mmol/L and a nadir of 123 mmol/L. Despite these shifts she experienced no adverse neurological symptoms. 3 weeks later she was again admitted for planned chemotherapy. During this admission she received the same medication treatment protocol as her prior stay, however, the management principles for ADI suggested by Cuesta et al. were applied. The result was a more stable serum sodium with a range of 130-145 mmol/L and no change in concentration by more than 5 mmol/L in a single 24 hour period. Patient was clinically stable and asymptomatic throughout her hospital stay Discussion: When compared to diabetes insipidus with intact thirst sensation, patients with ADI have been shown to be at increased risk for both hypernatremia and hyponatremia during inpatient admission. The risk is further increased when the admission is for an illness not related to pituitary dysfunction. This case represents an important clinical lesson in ADI where simple management principles led to a drastic change in the patient’s serum sodium. Fortunately, this patient tolerated the sodium shifts well, and did not require critical care interventions to correct her dysnatremia. Among the most important principles were transition from intranasal to oral DDAVP for a more predictable treatment response and the use of oral fluids instead of IV whenever possible. Applying these principles at the time of admission allowed for a better understanding of the treatment goals by the multidisciplinary healthcare team. Although ADI is rare, applying these simple interventions at the time of admission is likely to benefit all patients with diabetes insipidus. References: Cuesta, Martin; Hannon, Mark, Thompson, Christopher. Adipsic Diabetes Insipidus in Adult Patients.Pituitary, 2017; 20: 372-380
format Online
Article
Text
id pubmed-6552815
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65528152019-06-13 SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus Weaver, Travis Hoang, Thanh Warnock, Alicia J Endocr Soc Neuroendocrinology and Pituitary Background: Adipsic diabetes insipidus (ADI) is a rare condition with approximately 100 reported cases word wide. Inpatient management can be challenging as patients are predisposed to dysnatremia during this time. Societal guidelines offer little guidance in management of this complex disease. Case: A 62-year-old woman with a history of acromegaly with transphenoidal resection more than 20 years ago, complicated by post-operative hypothyroidism, adrenal insufficiency and adipsic diabetes insipidus presented for admission for a planned cycle on of chemotherapy for her recently diagnosed diffuse large B-cell lymphoma. At admission her initial serum sodium was 130 mmol/L (reference 135-145 mmol/L) near her baseline level. During her 8 day stay she experienced significant fluctuations of serum sodium with a peak level of 151 mmol/L and a nadir of 123 mmol/L. Despite these shifts she experienced no adverse neurological symptoms. 3 weeks later she was again admitted for planned chemotherapy. During this admission she received the same medication treatment protocol as her prior stay, however, the management principles for ADI suggested by Cuesta et al. were applied. The result was a more stable serum sodium with a range of 130-145 mmol/L and no change in concentration by more than 5 mmol/L in a single 24 hour period. Patient was clinically stable and asymptomatic throughout her hospital stay Discussion: When compared to diabetes insipidus with intact thirst sensation, patients with ADI have been shown to be at increased risk for both hypernatremia and hyponatremia during inpatient admission. The risk is further increased when the admission is for an illness not related to pituitary dysfunction. This case represents an important clinical lesson in ADI where simple management principles led to a drastic change in the patient’s serum sodium. Fortunately, this patient tolerated the sodium shifts well, and did not require critical care interventions to correct her dysnatremia. Among the most important principles were transition from intranasal to oral DDAVP for a more predictable treatment response and the use of oral fluids instead of IV whenever possible. Applying these principles at the time of admission allowed for a better understanding of the treatment goals by the multidisciplinary healthcare team. Although ADI is rare, applying these simple interventions at the time of admission is likely to benefit all patients with diabetes insipidus. References: Cuesta, Martin; Hannon, Mark, Thompson, Christopher. Adipsic Diabetes Insipidus in Adult Patients.Pituitary, 2017; 20: 372-380 Endocrine Society 2019-04-30 /pmc/articles/PMC6552815/ http://dx.doi.org/10.1210/js.2019-SUN-407 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Neuroendocrinology and Pituitary
Weaver, Travis
Hoang, Thanh
Warnock, Alicia
SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title_full SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title_fullStr SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title_full_unstemmed SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title_short SUN-407 A Clinical Lesson in Adipsic Diabetes Insipidus
title_sort sun-407 a clinical lesson in adipsic diabetes insipidus
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552815/
http://dx.doi.org/10.1210/js.2019-SUN-407
work_keys_str_mv AT weavertravis sun407aclinicallessoninadipsicdiabetesinsipidus
AT hoangthanh sun407aclinicallessoninadipsicdiabetesinsipidus
AT warnockalicia sun407aclinicallessoninadipsicdiabetesinsipidus